ThinkEquity Initiates Coverage on Virpax Pharmaceuticals | Virpax Pharmaceuticals

Mar 4, 2022

ThinkEquity Initiates Coverage on Virpax Pharmaceuticals

admin2022-10-21T08:35:52-04:00March 4th, 2022|Media|

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

© Virpax^® Pharmaceuticals. All Rights Reserved.

© Virpax^® Pharmaceuticals. All Rights Reserved.

Follow @VirpaxPharma

Follow @VirpaxPharma